Lung Cancer News and Research

Latest Lung Cancer News and Research

Research shows how Chlamydia pathogen invades human cells

Together with scientists from Paris and Munich, a team of researchers working under Prof. Dr. Johannes Hegemann and Dr. Katja Moelleken has published these findings in the journal Proceedings of the National Academy of Sciences of the United States of America.

5 Mar 2020

Researchers establish a gene expression profile associated with cachexia in cancer patients

It is estimated that as many as 80% of advanced-stage cancer patients may develop cachexia, a potentially fatal metabolic syndrome characterized by extreme weight loss and muscle wasting, but scientists do not yet fully understand why it is more frequently associated with certain kinds of tumor than others, or why not all cancer patients develop it.

3 Mar 2020

Canada's cancer burden will increase in 2020 as population ages

Nearly 1 in 2 Canadians are expected to receive a diagnosis of cancer in their lifetime, and cancer is the leading cause of death in the country.

2 Mar 2020

Coronavirus pathology findings shows how the disease affects the body

Coronavirus disease (COVID-19) is spreading rapidly across the globe. Since COVID-19 is a new disease, scientists are racing to determine the nature of the virus and how it affects the human body. Now, a team of scientists, have shed light on how the virus affects the respiratory tract. The study provides essential information and descriptions of the early phase pathology of COVID-19 infection.

1 Mar 2020

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

A new phase II trial finds that a combination of radiation therapy and immunotherapy led to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and neck squamous cell carcinoma

27 Feb 2020

Biomarkers in blood samples can predict clinical response to immunotherapy in metastatic NSCLC

Non-small cell lung cancer patients with higher measures of tumor mutations that show up in a blood test generally have a better clinical response to PD-1-based immunotherapy treatments than patients with a lower measure of mutations.

26 Feb 2020

Regular physical activity may improve well-being of African American cancer survivors

New research suggests that regular exercise may improve the well-being of African American cancer survivors, but most survivors do not meet current recommendations for physical activity.

25 Feb 2020

The golden state’s mixed record on lung cancer

It was a bewildering moment for Zach Jump, the American Lung Association's national director of epidemiology and statistics.

25 Feb 2020

Researchers uncover how cancer cells override environmental cues to consume energy

Using human lung cancer cells, UT Southwestern researchers have uncovered how cells in general modulate their energy consumption based on their surroundings and, furthermore, how cancer cells override those cues to maximize energy use.

24 Feb 2020

UT Dallas scientists awarded CPRIT grants for lung, kidney cancer research

The Cancer Prevention and Research Institute of Texas has awarded new grants totaling $1.8 million to two University of Texas at Dallas scientists for their research related to lung and kidney cancers.

23 Feb 2020

Comprehensive tumor profiling reveals why osteosarcoma does not respond to immunotherapy

Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally poor responses observed from treatment with immune checkpoint inhibitors, according to new research from The University of Texas MD Anderson Cancer Center.

22 Feb 2020

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer.

21 Feb 2020

Harmful levels of metal linked to DNA damage found in the urine of e-cigarette users

Researchers at the University of California, Riverside, have completed a cross-sectional human study that compares biomarkers and metal concentrations in the urine of e-cigarette users, nonsmokers, and cigarette smokers.

20 Feb 2020

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda).

20 Feb 2020

New biomarkers for diagnosis and prognosis of lung cancer identified

Applying bioinformatics to resolve biological problems. This is the objective of the research group of the University of Malaga "BI4NEXT", which, in one of its latest studies, developed in the Supercomputing and Bioinnovation Center based on biobank samples, has identified new biomarkers for the diagnosis, prognosis and even treatment of lung cancer.

20 Feb 2020

Lung Cancer News and Research

Latest Lung Cancer News and Research

Research shows how Chlamydia pathogen invades human cells

Researchers establish a gene expression profile associated with cachexia in cancer patients

Canada's cancer burden will increase in 2020 as population ages

Coronavirus pathology findings shows how the disease affects the body

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

Biomarkers in blood samples can predict clinical response to immunotherapy in metastatic NSCLC

Regular physical activity may improve well-being of African American cancer survivors

The golden state’s mixed record on lung cancer

Researchers uncover how cancer cells override environmental cues to consume energy

UT Dallas scientists awarded CPRIT grants for lung, kidney cancer research

Comprehensive tumor profiling reveals why osteosarcoma does not respond to immunotherapy

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Harmful levels of metal linked to DNA damage found in the urine of e-cigarette users

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

New biomarkers for diagnosis and prognosis of lung cancer identified

Both strands of microRNA cooperate to drive cancer growth and aggressiveness, research shows

Cancer risk in psoriatic patients

UCLA researchers identify new molecule that promotes airway health

Study provides insight into link between cancer driver gene and alternative splicing changes

Intratumoral heterogeneity linked to chemotherapy resistance in small-cell lung cancer

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in